Main
>
INFECTIOUS DISEASES
>
Bacteria Infectious Diseases+
>
Bacillus Anthracis Infection
>
Treatment
>
Co: USA. E. ObiltoxaxiMAb Inj.
>
Patent>USA Expiration: 2023. 07.15.
Patent>USA Expiration: 2023. 07.15.'s products
This section has no products